NCT05950776View on ClinicalTrials.gov

COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 15, 2021

Primary Completion Date

November 2, 2022

Study Completion Date

November 2, 2022

Conditions
Covid19
Interventions
BIOLOGICAL

MVA-SARS-2-S

Vaccination with MVA-SARS-2-S

OTHER

Placebo

Placebo

Sponsors
All Listed Sponsors
collaborator

German Center for Infection Research

OTHER

collaborator

Philipps University Marburg

OTHER

collaborator

Ludwig-Maximilians - University of Munich

OTHER

collaborator

University Hospital Tuebingen

OTHER

collaborator

CTC-NORTH

UNKNOWN

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT05950776 - COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults | Biotech Hunter | Biotech Hunter